XML 34 R22.htm IDEA: XBRL DOCUMENT v3.19.2
Nature of Business and Liquidity (Details)
6 Months Ended
Jun. 30, 2019
clinicalTrial
candidate
drug
project
technology
Product Information  
Number of core drug technologies | technology 3
Number of drug candidates | candidate 6
Number of drugs in clinical trials | drug 3
Number of clinical trials | clinicalTrial 4
Number of other drug development projects | project 5
Food and Drug Administration  
Product Information  
Market exclusivity extension period (years) 5 years
European Union  
Product Information  
Market exclusivity extension period (years) 10 years
Animal Life Science  
Product Information  
Ownership interest (percent) 10.00%